首页> 美国卫生研究院文献>Infection and Immunity >Severity of Allergic Airway Disease Due to House Dust Mite Allergen Is Not Increased after Clinical Recovery of Lung Infection with Chlamydia pneumoniae in Mice
【2h】

Severity of Allergic Airway Disease Due to House Dust Mite Allergen Is Not Increased after Clinical Recovery of Lung Infection with Chlamydia pneumoniae in Mice

机译:屋尘螨变应原引起的过敏性气道疾病的严重性在小鼠肺炎衣原体肺感染的临床恢复后没有增加

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chlamydia pneumoniae is associated with chronic inflammatory lung diseases like bronchial asthma and chronic obstructive pulmonary disease. The existence of a causal link between allergic airway disease and C. pneumoniae is controversial. A mouse model was used to address the question of whether preceding C. pneumoniae lung infection and recovery modifies the outcome of experimental allergic asthma after subsequent sensitization with house dust mite (HDM) allergen. After intranasal infection, BALB/c mice suffered from pneumonia characterized by an increased clinical score, reduction of body weight, histopathology, and a bacterial load in the lungs. After 4 weeks, when infection had almost resolved clinically, HDM allergen sensitization was performed for another 4 weeks. Subsequently, mice were subjected to a methacholine hyperresponsiveness test and sacrificed for further analyses. As expected, after 8 weeks, C. pneumoniae-specific antibodies were detectable only in infected mice and the titer was significantly higher in the C. pneumoniae/HDM allergen-treated group than in the C. pneumoniae/NaCl group. Intriguingly, airway hyperresponsiveness and eosinophilia in bronchoalveolar lavage fluid were significantly lower in the C. pneumoniae/HDM allergen-treated group than in the mock/HDM allergen-treated group. We did observe a relationship between experimental asthma and chlamydial infection. Our results demonstrate an influence of sensitization to HDM allergen on the development of a humoral antibacterial response. However, our model demonstrates no increase in the severity of experimental asthma to HDM allergen as a physiological allergen after clinically resolved severe chlamydial lung infection. Our results rather suggest that allergic airway disease and concomitant cellular changes in mice are decreased following C. pneumoniae lung infection in this setting.
机译:肺炎衣原体与慢性炎症性肺病如支气管哮喘和慢性阻塞性肺病有关。过敏性气道疾病与肺炎衣原体之间存在因果关系是有争议的。使用小鼠模型来解决先前的肺炎衣原体肺部感染和恢复在随后对屋尘螨(HDM)过敏原致敏后是否改变了实验性过敏性哮喘的结果的问题。鼻内感染后,BALB / c小鼠患有肺炎,其特征在于临床评分增加,体重减轻,组织病理学改变和肺部细菌负荷。 4周后,当感染在临床上几乎已消退时,又对HDM过敏原进行了4周的致敏。随后,对小鼠进行乙酰甲胆碱高反应性测试并处死以进行进一步分析。如预期的那样,在8周后,仅在感染的小鼠中检测到肺炎衣原体特异性抗体,并且在肺炎衣原体/ HDM过敏原处理组中的滴度明显高于肺炎衣原体/ NaCl组。有趣的是,肺炎衣原体/ HDM过敏原治疗组的支气管肺泡灌洗液中气道高反应性和嗜酸性粒细胞明显低于模拟/ HDM过敏原治疗组。我们确实观察到实验性哮喘与衣原体感染之间的关系。我们的结果表明,对HDM过敏原致敏对体液抗菌反应的发展有影响。但是,我们的模型表明,在临床解决严重的衣原体肺部感染后,作为一种生理变应原,HDM变应原对实验性哮喘的严重性没有增加。我们的研究结果表明,在这种情况下,肺炎衣原体肺部感染后,小鼠的变态反应性气道疾病和伴随的细胞变化减少了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号